Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Siddhartha Deb
Affiliation
Olivia Newton-John Cancer Research Institute
ORCID
Career Start Year
2002
Papers
41
H Index
20
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36831687
Prognostic and Predictive Biomarkers in Familial Breast Cancer.
Cancers (Basel)
2023
35186255
Gynaecomastia-like change of a female breast with tri-layer ductal epithelium as described in the male breast.
J Surg Case Rep
2022
35565421
Paracrine IL-6 Signaling Confers Proliferation between Heterogeneous Inflammatory Breast Cancer Sub-Clones.
Cancers (Basel)
2022
34420794
Not all low grade dysplasia in Barrett's oesophagus is the same: using specific histological criteria in predicting progression to neoplasia.
Pathology
2021
31100936
Immunoprofiling of Breast Cancer Antigens Using Antibodies Derived from Local Lymph Nodes.
Cancers (Basel)
2019
31482136
Tumor inherent interferon regulators as biomarkers of long-term chemotherapeutic response in TNBC.
NPJ Precis Oncol
2019
31160311
Retraction: The E3-ligase E6AP Represses Breast Cancer Metastasis via Regulation of ECT2-Rho Signaling.
Cancer Res
2019
29658001
Glut-1 expression in small cervical biopsies is prognostic in cervical cancers treated with chemoradiation.
Clin Transl Radiat Oncol
2017
28257959
The Immune Microenvironment, Genome-wide Copy Number Aberrations, and Survival in Mesothelioma.
J Thorac Oncol
2017
28477016
E6AP promotes prostate cancer by reducing p27 expression.
Oncotarget
2017
28211079
GATA3 expression in triple-negative breast cancers.
Histopathology
2017
28369925
Cousins not twins: intratumoural and intertumoural heterogeneity in syndromic neuroendocrine tumours.
J Pathol
2017
28416734
The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma.
Oncotarget
2017
26768033
The cancer genetics and pathology of male breast cancer.
Histopathology
2016
27780599
Calretinin but not caveolin-1 correlates with tumour histology and survival in malignant mesothelioma.
Pathology
2016
27231202
The E3-ligase E6AP Represses Breast Cancer Metastasis via Regulation of ECT2-Rho Signaling.
Cancer Res
2016
25633981
Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer.
Dis Model Mech
2015
26152113
Comparative microRNA profiling of sporadic and BRCA1 associated basal-like breast cancers.
BMC Cancer
2015
26173619
¹â¸F-FDG PET/CT following chemoradiation of uterine cervix cancer provides powerful prognostic stratification independent of HPV status: a prospective cohort of 105 women with mature survival data.
Eur J Nucl Med Mol Imaging
2015
24077944
Characterization of a novel tumorigenic esophageal adenocarcinoma cell line: OANC1.
Dig Dis Sci
2014
25490678
Mutational profiling of familial male breast cancers reveals similarities with luminal A female breast cancer with rare TP53 mutations.
Br J Cancer
2014
25464844
Cohesin Rad21 mediates loss of heterozygosity and is upregulated via Wnt promoting transcriptional dysregulation in gastrointestinal tumors.
Cell Rep
2014
25331261
Methylation profiling of ductal carcinoma in situ and its relationship to histopathological features.
Breast Cancer Res
2014
24916286
Lymph node status as a prognostic indicator after preoperative neoadjuvant chemoradiotherapy of rectal cancer.
Colorectal Dis
2014
24874483
COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatment.
Br J Cancer
2014
24548858
RAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in KRAS mutant colorectal carcinomas.
Br J Cancer
2014
24406338
FOXP3 over-expression inhibits melanoma tumorigenesis via effects on proliferation and apoptosis.
Oncotarget
2014
23434054
Frequency of fibroblast growth factor receptor 1 gene amplification in oral tongue squamous cell carcinomas and associations with clinical features and patient outcome.
Oral Oncol
2013
23971979
PIK3CA mutations are frequently observed in BRCAX but not BRCA2-associated male breast cancer.
Breast Cancer Res
2013
23935846
The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer.
PLoS One
2013
21768359
Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737.
Proc Natl Acad Sci U S A
2012
23146383
Genotypic and phenotypic analysis of familial male breast cancer shows under representation of the HER2 and basal subtypes in BRCA-associated carcinomas.
BMC Cancer
2012
22543203
A prospective pathologic study to define the clinical target volume for partial breast radiation therapy in women with early breast cancer.
Int J Radiat Oncol Biol Phys
2012
21115342
Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate.
Eur J Cancer
2011
21930782
Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14.
Mol Cell Biol
2011
21317925
The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene.
Oncogene
2011
20958947
Microcystic adnexal carcinoma of the skin: the role of adjuvant radiotherapy.
J Med Imaging Radiat Oncol
2010
19815416
Primary anaplastic pilocytic astrocytoma.
J Clin Neurosci
2009
18519755
ECSA/DPPA2 is an embryo-cancer antigen that is coexpressed with cancer-testis antigens in non-small cell lung cancer.
Clin Cancer Res
2008
16411876
Cryptococcal dementia in a patient with sarcoidosis.
Med J Aust
2006
12082628
TERT regulates cell survival independent of telomerase enzymatic activity.
Oncogene
2002
1 - 41 of 41
Column Actions
Search
Recommended Authors
Charlotte K Y Ng
University of Bern
Career Start Year
2009
Number of shared co-authors
3
Felipe C Geyer
Instituto Do Cancer Do Estado de Sao Paulo
Career Start Year
2009
Number of shared co-authors
4
Salvatore Piscuoglio
University of Basel
Career Start Year
2008
Number of shared co-authors
1
Francisco Beca
Stanford University School of Medicine
Career Start Year
2008
Number of shared co-authors
0
Samuel Leung
University of British Columbia
Career Start Year
2007
Number of shared co-authors
2
Hannah Y Wen
Memorial Sloan Kettering Cancer Center
Career Start Year
2007
Number of shared co-authors
3
Leonard Da Silva
Pathology Queensland The Royal Brisbane and Women's Hospital Brisbane Qld Australia.
Career Start Year
2007
Number of shared co-authors
6
Caterina Marchi??
University of Turin, Candiolo Cancer Institute, FPO-IRCCS
Career Start Year
2005
Number of shared co-authors
1
Andrew H Beck
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year
2004
Number of shared co-authors
0
Karin Jirstr??m
Lund University
Career Start Year
2003
Number of shared co-authors
0
Peter T Simpson
UQ Centre for Clinical Research, The University of Queensland
Career Start Year
2003
Number of shared co-authors
3
Maryou B Lambros
The Institute of Cancer Research
Career Start Year
2002
Number of shared co-authors
3
Nicola Fusco
IEO European Institute of Oncology IRCCS
Career Start Year
2002
Number of shared co-authors
1
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Career Start Year
2002
Number of shared co-authors
3
Darran P O'Connor
UCD Conway Institute, University College Dublin
Career Start Year
2001
Number of shared co-authors
0
Ingrid Hedenfalk
Lund University and Skane University Hospital
Career Start Year
1997
Number of shared co-authors
0
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Career Start Year
1996
Number of shared co-authors
10
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year
1996
Number of shared co-authors
1
Susan J Done
University Health Network
Career Start Year
1994
Number of shared co-authors
2
David G Huntsman
University of British Columbia
Career Start Year
1994
Number of shared co-authors
7
Rosemary L Balleine
Westmead Institute for Medical Research, The University of Sydney
Career Start Year
1993
Number of shared co-authors
6
John M S Bartlett
University of Edinburgh
Career Start Year
1992
Number of shared co-authors
6
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year
1992
Number of shared co-authors
4
Ben Ho Park
Vanderbilt University Medical Center
Career Start Year
1990
Number of shared co-authors
0
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year
1989
Number of shared co-authors
2
Paul J van Diest
University Medical Center Utrecht
Career Start Year
1989
Number of shared co-authors
2
Laura J Van't Veer
University of California San Francisco
Career Start Year
1984
Number of shared co-authors
2
Hans-Peter Sinn
Pathologisches Institut, Universitatsklinikum Heidelberg
Career Start Year
1981
Number of shared co-authors
3
Irene L Andrulis
University of Toronto
Career Start Year
1977
Number of shared co-authors
5
Jeffrey S Ross
Foundation Medicine
Career Start Year
1974
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Jonathan Cebon
Australia Olivia Newton-John Cancer Research Institute, La Trobe University
Co-authored papers
4
Thomas John
Peter MacCallum Cancer Centre
Co-authored papers
4
Paul Mitchell
Olivia Newton-John Cancer Research Institute
Co-authored papers
3
Carmel Murone
Olivia Newton-John Cancer Research Institute
Co-authored papers
3
Stephen Barnett
Royal Melbourne Hospital
Co-authored papers
3
Marzena Walkiewicz
Olivia Newton-John Cancer Research Institute
Co-authored papers
3
Simon Knight
Churchill Hospital
Co-authored papers
3
Arun A Azad
Peter MacCallum Cancer Centre
Co-authored papers
3
Yong-Hui Jiang
Yale University School of Medicine
Co-authored papers
2
Joshy George
Peter MacCallum Cancer Centre
Co-authored papers
2
Robyn L Ward
University of Sydney
Co-authored papers
2
Nasser K Altorki
New York-Presbyterian Hospital
Co-authored papers
2
Gavin M Wright
St. Vincent's Hospital, University of Melbourne
Co-authored papers
2
Paul C Boutros
University of California los angeles
Co-authored papers
2
David N Watkins
Research Institute in Oncology and Hematology
Co-authored papers
2
Khashayar Asadi
Austin Hospital
Co-authored papers
2
Nicholas J Hawkins
School of Public Health, Imperial College London
Co-authored papers
2
Bibhusal Thapa
Northern Hospital
Co-authored papers
2
Sunil R Lakhani
University of Queensland
Co-authored papers
2
Yao-Tseng Chen
From Population Health Services (Chen)
Co-authored papers
2
Prudence A Russell
St Vincent's Hospital
Co-authored papers
2
Gordon K Smyth
The University of Melbourne
Co-authored papers
2
Richard A Scolyer
Co-authored papers
1
Kara L Britt
Co-authored papers
1
John M Mariadason
Olivia Newton-John Cancer Research Institute
Co-authored papers
1
Colin D Clyne
Co-authored papers
1
Shane White
Olivia Newton-John Cancer Wellness and Research Centre
Co-authored papers
1
David D L Bowtell
Peter MacCallum Cancer Centre
Co-authored papers
1
Philippe Lambin
Maastricht University
Co-authored papers
1
Emma L Duncan
Co-authored papers
1
1 - 30